Phase II Trial of First-line Doxycycline for Ocular Adnexal Marginal Zone Lymphoma Treatment
Clinical trial NCT01820910 · COMPLETED
Trial details
- NCT number
- NCT01820910
- Sponsor
- International Extranodal Lymphoma Study Group (IELSG)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-03-19
- Primary completion
- 2016-05-01
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.